Similar companies
| Company | Business Outlook | |
|---|---|---|
 |
Align TechnologyALGN |
52 1.9% |
 |
DentsplyXRAY |
42 2.3% |
 |
LeMaitre VascularLMAT |
45 7.1% |
 |
iRhythm TechnologiesIRTC |
25 4.2% |
 |
Silk Road MedicalSILK |
66 0% |
Month over Month
Employee view on business outlook (0 - 100)
| Dec 2024 | 38 | |
| Nov 2024 | 40 | |
| Oct 2024 | 36 | |
| Sep 2024 | 37 |
How do employees feel about the future at NovoCure?
The Business Outlook at NovoCure is negative, according to employees. The rating, which is an average compiled from the top review sites in the US, is below average at 38 out of 100. Additionally, this rating has been trending downward in comparison to the previous month.
Analyzing Business Outlook, how is NovoCure performing compared to its industry peers?
Compared to its peers, NovoCure ranks in the 40th percentile when it comes to Business Outlook.
How has the business outlook at NovoCure changed over the last couple of months
In recent months, NovoCure's employees have reported a shift towards a more positive business outlook, indicating improved company morale and potentially leading to increased market competitiveness and enhanced company performance.
Why is it important to track the business outlook at NovoCure?
Tracking a company's business outlook is important as a positive outlook can indicate future growth and profitability and attract new talent, while a negative outlook can discourage talent and imply demotivated employees. Additionally, data shows that companies with a high business outlook tend to perform better on the stock market compared to those with a lower business outlook.
Sign up and get more insights on the business outlook at NovoCure.
